Assembly Biosciences Inc (NASDAQ:ASMB)

46.53
Delayed Data
As of 4:00pm ET
 -0.11 / -0.24%
Today’s Change
18.60
Today|||52-Week Range
67.36
+2.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-23.8M-28.5M-44.3M-42.8M
 
 
 
 
 
Depreciation11.0K65.0K80.3K219.2K
 
 
 
 
 
Total Other Cash Flow11.3M7.9M6.2M9.2M
 
 
 
 
 
Funds From Operations-12.5M-20.5M-38.6M-42.4M
 
 
 
 
 
Funds From/For Other Operating Expenses2.5M-1.9M-3.8M-44.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-15.0M-18.6M-34.9M1.9M
 
 
 
 
 
 
InvestingIncrease In Investments-82.0K-69.8M-8.0M-48.2M
 
 
 
 
 
Decrease In Investments0.005.0M44.3M33.5M
 
 
 
 
Capital Expenditures-150.0K-58.3K-146.3K-864.6K
 
 
 
 
 
Fixed Asset Disposal509.4K150.000.000.00
 
 
 
Net Cash Flow Investing277.4K-64.9M36.2M-15.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale16.7M81.6M152.6K67.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00----0.00--
Cash Dividends Paid - Total0.00----0.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing16.7M81.6M152.6K67.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash2.0M-1.9M1.5M53.5M